From: Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections
Characteristics | VAD infection n = 18 | No VAD infection n = 17 |
---|---|---|
Age, years; mean (SD) | 52.3 (9.7) | 39.1 (20) |
Gender, male; n (%) | 15 (83.3) | 14 (82.4) |
BMI, kg/m2; mean (SD) | 28.4 (6.1) | 22.9 (6) |
Median time from VAD implantation to transplantation, days; median (IQR) | 293.5 (121–593) | 101 (37.5-206) |
INTERMACS score; median (IQR) | 1.5 (1–4) | 2 (1–3) |
Creatinine, μmol/l; mean (SD) | 105.3 (58.6) | 90.9 (35.6) |
Type of VAD; n (%) | Â | Â |
 - Heartmate® II  - Berlin Heart® EXCOR  - Heartware®  - Thoratec®  - Levitronics® | 9 (37.1) 6 (34.3) 1 (14.3) 2 (11.4) 0 (0.0) | 5 (29.4) 6 (35.3) 4 (23.5) 1 (5.8) 1 (5.8) |
Active infection at the time of transplant | 10/18 (55.5) | - |